Reynoso Jamie L. (CIK 1839066) reported 45 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-06). Recent activity: Sell CLOV (6,229 shares), Sell CLOV (2,360 shares), Sell CLOV (6,350 shares), Sell CLOV (7,289 shares), Sell CLOV (12,712 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-06 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Sell | 6,229 | $32,765 |
| 2026-06-18 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Sell | 2,360 | $11,281 |
| 2026-06-16 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Sell | 6,350 | $29,274 |
| 2026-06-11 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Sell | 7,289 | $35,789 |
| 2026-04-16 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Sell | 12,712 | $25,932 |
| 2026-04-07 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Sell | 6,197 | $10,659 |
| 2026-04-03 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Buy | 159,384 | $0 |
| 2026-03-18 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Sell | 5,833 | $11,141 |
| 2026-03-17 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Sell | 8,945 | $17,711 |
| 2026-03-17 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Sell | 6,187 | $12,250 |
| 2026-01-20 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Sell | 14,732 | $41,397 |
| 2026-01-20 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Sell | 4,597 | $11,860 |
| 2026-01-07 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Sell | 2,102 | $5,318 |
| 2026-01-05 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Sell | 8,109 | $19,543 |
| 2025-12-18 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Sell | 4,913 | $12,823 |
| 2025-12-16 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Sell | 12,567 | $33,931 |
| 2025-12-16 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Sell | 8,691 | $23,466 |
| 2025-11-05 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Sell | 30,385 | $108,778 |
| 2025-11-04 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Sell | 101,917 | $359,767 |
| 2025-11-04 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Sell | 29,513 | $104,181 |
| 2025-10-21 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Sell | 16,514 | $44,423 |
| 2025-10-17 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Sell | 71,432 | $200,010 |
| 2025-10-07 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Sell | 8,706 | $22,549 |
| 2025-10-07 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Sell | 2,012 | $5,332 |
| 2025-09-19 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | Sell | 4,914 | $15,184 |
Source: SEC Form 4 filings · as of 2026-07-06